$ATHX News Article - Athersys Announces Favorable Preclinical Results for MultiStem Treatment in Defense Department Radiation Countermeasure Study and Upcoming Webinar to Review Preclinical Research With MultiStem Across Multiple Indications
https://marketwirenews.com/news-releases/athe...90187.html